VolitionRX Ltd

ASE:VNRX

0.68

-0.02 (-2.93%)

5:23:54 PM EDT: $0.66 -0.02 (-2.88%)

Market Cap (Intraday)	62.59M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$0.65 Million
Adjusted EPS	-$0.08

See more estimates

10-Day MA	$0.68
50-Day MA	$0.65
200-Day MA	$0.78

See more pivots

VolitionRX Ltd Stock, ASE:VNRX

1489 West Warm Springs Road, Suite 110, Henderson, Nevada 89014

United States of America

Phone: +1.646.650.1351

Number of Employees: 110

http://www.volition.com

Description

VolitionRX Ltd. engages in the development of blood-based cancer tests to help diagnose a range of cancers. Its products include the Nucleosomics platform that identifies and measures nucleosomes in the bloodstream or other bodily fluids. The company was founded on September 24, 1998 and is headquartered in Henderson, NV.